21
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Loss of Reirradiation Tolerance in the Kidney with Increasing Time after Single or Fractionated Partial Tolerance Doses

, , &
Pages 169-179 | Received 02 Nov 1993, Accepted 16 Mar 1994, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fiona A. Stewart. (1999) Re-Treatment After Full-Course Radiotherapy: Is It a Viable Option?. Acta Oncologica 38:7, pages 855-862.
Read now
J.H. Hendry & C.M.L. West. (1995) Implications of Delayed Reproductive Cell Death (Lethal Mutations/Genomic Instability) for the Interpretation of Tissue Responses. International Journal of Radiation Biology 68:4, pages 363-367.
Read now

Articles from other publishers (23)

Н.С. Карамян & М.К. Арустамян. (2022) О ЦЕЛЕСООБРАЗНОСТИ ПРОВЕДЕНИЯ ПОВТОРНОЙ РАДИОТЕРАПИИ ПРИ РЕЦИДИВАХ И ПРОДОЛЖЕННОМ РОСТЕ РАНЕЕ ОБЛУЧЕННЫХ ОПУХОЛЕЙ РАЗЛИЧНОЙ ЛОКАЛИЗАЦИИ. MEDICINE, SCIENCE AND EDUCATION:34, pages 29-36.
Crossref
Ներսես Քարամյան, Միքայել Առուստամյան, Սևանա Աբնուսի & Վահե Տեր-Մինասյան. (2022) Տարբեր տեղակայման ուռուցքների կրկնակի ճառագայթում. մեկ կլինիկայի փորձը Պրոսպեկտիվ հետազոտության նախնական արդյունքների ամփոփում. Armenian Journal of Health & Medical Sciences, pages 48-55.
Crossref
William H McBride & Dörthe Schaue. (2020) Radiation‐induced tissue damage and response. The Journal of Pathology 250:5, pages 647-655.
Crossref
Luciana Caravatta, Francesco Fiorica, Consuelo Rosa, Luca Boldrini, Anna Rita Alitto, Alessia Nardangeli, Francesco Dionisi, Lavinia Bianco, Fernando Munoz, Marco Lupattelli, Giovanna Mantello, Domenico Genovesi & Mariangela Massaccesi. (2019) Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Die Rolle der oberen abdominalen Rebestrahlung bei gastrointestinalen Malignomen: Ein systematischer Review über kumulative Dosen, Toxizität und Outcome im Auftrag der Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Strahlentherapie und Onkologie 196:1, pages 1-14.
Crossref
W. Dörr & D. Gabryś. (2018) The Principles and Practice of Re-irradiation in Clinical Oncology: An Overview. Clinical Oncology 30:2, pages 67-72.
Crossref
Carsten Nieder & Johannes A. Langendijk. 2017. Re-Irradiation: New Frontiers. Re-Irradiation: New Frontiers 1 15 .
Mark W. Konijnenberg, Wout A. P. Breeman, Erik de Blois, Ho Sze Chan, Otto C. Boerman, Peter Laverman, Petra Kolenc-Peitl, Marleen Melis & Marion de Jong. (2014) Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount. EJNMMI Research 4:1.
Crossref
Alexander V. AkleyevAlexander V. Akleyev. 2014. Chronic Radiation Syndrome. Chronic Radiation Syndrome 55 129 .
F.A. Stewart, A.V. Akleyev, M. Hauer-Jensen, J.H. Hendry, N.J. Kleiman, T.J. MacVittie, B.M. Aleman, A.B. Edgar, K. Mabuchi, C.R. Muirhead, R.E. Shore & W.H. Wallace. (2012) ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context. Annals of the ICRP 41:1-2, pages 1-322.
Crossref
DAVID A. BOMMARITO, MICHAEL S. KENT, KIM A. SELTING, CAROLYN J. HENRY & JIMMY C. LATTIMER. (2010) REIRRADIATION OF RECURRENT CANINE NASAL TUMORS. Veterinary Radiology & Ultrasound 52:2, pages 207-212.
Crossref
C. Bourgier, M.-C. Vozenin & É. Deutsch. (2010) Réirradiation des tissus sains : données radiobiologiques précliniques. Cancer/Radiothérapie 14:6-7, pages 412-415.
Crossref
Carsten Nieder & Johannes A. Langendijk. 2011. Re-irradiation: New Frontiers. Re-irradiation: New Frontiers 1 12 .
Nicolaus Andratschke, Andrea Schnaitera, Wolfgang A. Weber, Lu Caia, Sabine Schill, Nicole Wiedenmann, Markus Schwaiger, Michael Molls & Carsten Nieder. (2006) Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction. International Journal of Radiation Oncology*Biology*Physics 64:5, pages 1513-1518.
Crossref
Vicente Pedraza Muriel. (2006) The impact on oncology of the interaction of radiation therapy and radiobiology. Clinical and Translational Oncology 8:2, pages 83-93.
Crossref
Eric P Cohen & Mike E.C Robbins. (2003) Radiation nephropathy. Seminars in Nephrology 23:5, pages 486-499.
Crossref
Søren M. Bentzen & Stanley Dische. (2001) Late morbidity: the Damocles Sword of radiotherapy?. Radiotherapy and Oncology 61:3, pages 219-221.
Crossref
Ellen van Kleef, Marcel Verheij, Hans te Poele, Yvonne Oussoren, Luc Dewit & Fiona Stewart. (2000) In Vitro and In Vivo Expression of Endothelial von Willebrand Factor and Leukocyte Accumulation after Fractionated Irradiation . Radiation Research 154:4, pages 375-381.
Crossref
Carsten Nieder, Luka Milas & K. Kian Ang. (2000) Tissue tolerance to reirradiation. Seminars in Radiation Oncology 10:3, pages 200-209.
Crossref
Moshe H. Maor, Luceil B. North, Fernando F. Cabanillas, Angie L. Ames, Mark A. Hess & James D. Cox. (1998) Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. International Journal of Radiation Oncology*Biology*Physics 41:3, pages 647-650.
Crossref
Klaus-Rüdiger Trott. (1996) Retreatment tolerance of the heart. International Journal of Radiation Oncology*Biology*Physics 36:4, pages 985-986.
Crossref
Jan Wondergem, Frank J.M. van Ravels, Ivonne W.C. Reijnart & Erwin G. Strootman. (1996) Reirradiation tolerance of the rat heart. International Journal of Radiation Oncology*Biology*Physics 36:4, pages 811-819.
Crossref
C. Irwin, A. Fyles, C.S. Wong, C.M. Cheung & Y. Zhu. (1996) Late renal function following whole abdominal irradiation. Radiotherapy and Oncology 38:3, pages 257-261.
Crossref
Akmal Safwat, Ole S. Nielsen, Hoda Abd El-Bakky & Jens Overgaard. (1995) Renal damage after total body irradiation in a mouse model for bone marrow transplantation: effect of radiation dose rate. Radiotherapy and Oncology 34:3, pages 203-209.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.